Bristol-Myers Squibb Company
TREATMENT OF CANCER WITH ANTI-GITR AGONIST ANTIBODIES

Abstract:

Provided herein are methods for treating cancer, comprising administering to a subject having cancer a therapeutically effective amount of an anti-GITR antibody alone or together with an anti-PD-1 or anti-PD-L1 antibody.